United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 475,800 | 363,600 | 200,900 | 28,300 | 514,800 |
| Depreciation Amortization | 49,900 | 37,300 | 24,900 | 12,500 | 49,900 |
| Accounts receivable | -41,300 | -55,400 | -16,100 | 16,300 | -6,000 |
| Accounts payable and accrued liabilities | -12,500 | 22,000 | 2,200 | -25,000 | 38,600 |
| Other Working Capital | -174,200 | -141,100 | -94,800 | -21,100 | 63,100 |
| Other Operating Activity | 300,500 | 197,200 | 120,900 | 78,800 | 95,300 |
| Operating Cash Flow | $598,200 | $423,600 | $238,000 | $89,800 | $755,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,736,200 | -1,244,400 | -715,400 | -450,100 | -2,205,000 |
| PPE Investments | -120,800 | -50,200 | -26,900 | -10,600 | -56,900 |
| Purchase Of Investment | N/A | N/A | -7,800 | N/A | N/A |
| Sale Of Investment | 1,370,100 | 1,003,500 | 694,900 | 454,400 | 1,523,400 |
| Investing Cash Flow | $-486,900 | $-291,100 | $-55,200 | $-6,300 | $-738,500 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 55,600 | 47,900 | 31,100 | 20,300 | 38,500 |
| Common Stock Repurchased | -10,800 | -10,600 | N/A | -10,200 | -3,700 |
| Other Financing Activity | 0 | 0 | -10,400 | 0 | -51,700 |
| Financing Cash Flow | $44,800 | $37,300 | $20,700 | $10,100 | $-16,900 |
| Beginning Cash Position | 738,700 | 738,700 | 738,700 | 738,700 | 738,400 |
| End Cash Position | 894,800 | 908,500 | 942,200 | 832,300 | 738,700 |
| Net Cash Flow | $156,100 | $169,800 | $203,500 | $93,600 | $300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 598,200 | 423,600 | 238,000 | 89,800 | 755,700 |
| Capital Expenditure | -120,800 | -50,200 | -26,900 | -10,600 | -59,300 |
| Free Cash Flow | 477,400 | 373,400 | 211,100 | 79,200 | 696,400 |